Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
m.fl.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
m.fl.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Thomas Karsten Kilvær
:
High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
Nikita Shvetsov,
Morten Grønnesby,
Edvard Pedersen,
Kajsa Møllersen,
Lill-Tove Rasmussen Busund,
Ruth Schwienbacher
m.fl.:
A Pragmatic Machine Learning Approach to Quantify Tumor-Infiltrating Lymphocytes in Whole Slide Images
Hallgeir Selven,
Sigve Andersen,
Mona Irene Pedersen,
Ana Paola Lombardi,
Lill-Tove Rasmussen Busund,
Thomas Karsten Kilvær
:
High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
m.fl.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
British Journal of Cancer 2021
DOI
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Lise Martine Ingebriktsen,
Roy M. Bremnes
m.fl.:
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
Hallgeir Selven,
Lill-Tove Rasmussen Busund,
Sigve Andersen,
Roy M. Bremnes,
Thomas Karsten Kilvær
:
High expression of microRNA‑126 relates to favorable prognosis for colon cancer patients
Maria Jenvin Støen,
Sigve Andersen,
Mehrdad Rakaee,
Mona I. Pedersen,
Lise Martine Ingebriktsen,
Tom Dønnem
m.fl.:
Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
m.fl.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
m.fl.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Jørg Vik,
Luigi de Petris,
Tom Dønnem
m.fl.:
Differential prognostic impact of platelet-derived growth factor receptor Expression in NSCLC
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Turid Hellevik,
Arne Östman,
Carina Strell,
Roy M. Bremnes
m.fl.:
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
m.fl.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Clinical Lung Cancer 2018
DOI
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
m.fl.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
m.fl.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
m.fl.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Cancer Immunology and Immunotherapy 2017
ARKIV /
DOI
Samer Al-Saad,
Elin Richardsen,
Thomas Karsten Kilvær,
Tom Dønnem,
Sigve Andersen,
Mehrdad Rakaee
m.fl.:
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer
Tom Dønnem,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen,
Sigurd Hald
m.fl.:
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Annals of Oncology 2016
DOI
Roy M. Bremnes,
Lill-Tove Busund,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen
m.fl.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Journal of Thoracic Oncology 2016
DOI
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
m.fl.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
Mehrdad Rakaee,
Lill-Tove Busund,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Sigve Andersen
m.fl.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Mehrdad Rakaee,
Samer Al-Saad,
Ramona Johansen Maurseth,
Khalid Al-Shibli
m.fl.:
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
British Journal of Cancer 2016
ARKIV /
DOI
Kaja Skjefstad,
Thea Grindstad,
Mehrdad Rakaee,
Elin Richardsen,
Tom Dønnem,
Thomas Karsten Kilvær
m.fl.:
Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer
Sigurd Hald,
Yury Kiselev,
Samer Al-Saad,
Elin Richardsen,
Charles Johannessen,
Marte Eilertsen
m.fl.:
Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: Combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
Tom Dønnem,
Sigurd Hald,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Thomas Karsten Kilvær
m.fl.:
Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
Clinical Cancer Research 2015
DOI
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Turid Hellevik,
Samer Al-Saad,
Erna-Elise Paulsen,
Roy M. Bremnes
m.fl.:
Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Ramona Johansen Maurseth,
Samer Al-Saad,
Sigurd Hald
m.fl.:
CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigurd Hald,
Tom Wilsgaard,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer - A structured review with meta-analysis
Thomas Karsten Kilvær,
Eivind Smeland,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Al-Shibli
m.fl.:
Prognostic impact of Skp2, ER and PGR in male and female patients with soft tissue sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Al-Shibli
m.fl.:
Prognostic Impact of Jab1, p16, p21, p62, Ki67 and Skp2 in Soft Tissue Sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
m.fl.:
Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
m.fl.:
Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas
Eivind Smeland,
Thomas Karsten Kilvær,
Sveinung Wergeland Sørbye,
Andrey Yurjevich Valkov,
Sigve Andersen,
Roy M. Bremnes
m.fl.:
Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Tom Dønnem,
Eivind Smeland,
Roy M. Bremnes
m.fl.:
The Prognostic Impact of TGF-beta 1, Fascin, NF-kappa B and PKC-zeta Expression in Soft Tissue Sarcomas
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Tom Dønnem,
Eivind Smeland,
Roy M. Bremnes
m.fl.:
Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas
International Journal of Oncology 2011
DOI
Sveinung Wergeland Sørbye,
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Tom Dønnem,
Eivind Smeland,
Khalid Ibrahim Al-Shibli
m.fl.:
Prognostic Impact of Lymphocytes in Soft Tissue Sarcomas
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Eivind Smeland,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients
Journal of Translational Medicine 2011
ARKIV /
DOI
Andrey Yurjevich Valkov,
Thomas Karsten Kilvær,
Sveinung Wergeland Sørbye,
Tom Dønnem,
Eivind Smeland,
Roy M. Bremnes
m.fl.:
The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas
Journal of Translational Medicine 2011
ARKIV /
DOI
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Tom Dønnem,
Eivind Smeland,
Roy M. Bremnes
m.fl.:
Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival
Thomas Karsten Kilvær,
Andrey Yurjevich Valkov,
Sveinung Wergeland Sørbye,
Eivind Smeland,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
m.fl.:
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis